Atlas Private Wealth Advisors Clovis Oncology, Inc. Transaction History

Atlas Private Wealth Advisors

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2020 Jan 29, 2021	SELL	$4.13 - $6.41 $20,650 - $32,050	-5,000 Closed	0 $0
Q3 2020 Oct 27, 2020	BUY	$4.82 - $7.72 $24,100 - $38,600	5,000 New	5,000 $29,000

166

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

Get notified when there are updates to the investment portfolio of Atlas Private Wealth Advisors, based on Form 13F filings with the SEC.

Stay updated on Atlas Private Wealth Advisors with notifications on news.